• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Receptos

edit

Receptos is a privately-held drug discovery and development company which utilizes pioneering G protein-coupled receptor (GPCR) technology to facilitate information-driven drug design for developing best- and first-in-class drugs.

Recent Milestones

edit

• 
  Receptos received $10.8M in Venture Round funding. (3/2/12)
  Posted 3/2/12 at 7:49pm via dowjones.com
• 
  Receptos received $25M in Series A funding. (11/23/09)
  Posted 11/23/09 at 6:59pm via fiercebiotech.com
• 
  Receptos added Chrysa Mineo as Vice President, Corporate Development.
  Posted 11/23/09 at 6:59pm
• 
  Receptos added Marcus F. Boehm as Vice President, Chemistry and co-Founder.
  Posted 11/23/09 at 6:59pm
• 
  Receptos added James R. Schmidt as Vice President, Finance and Administration.
  Posted 11/23/09 at 6:59pm
• 
  Receptos added Faheem Hasnain as President and CEO.
  Posted 12/5/10 at 7:37pm

Videos

Screenshots

edit

Above: Home Page
Uploaded: 11/24/09

Sources

1. Receptos raises $25M in Series A (fiercebiotech.com) [edit]
2. Receptos Raises $10.8M Toward New Round, Plans Phase II Trials (fis.dowjones.com) [edit]